Aldo N Serafini


  • 3985 Citations
1972 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Aldo N Serafini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Radionuclide Imaging Medicine & Life Sciences
Technetium Medicine & Life Sciences
Radioimmunodetection Medicine & Life Sciences
Blood Platelets Medicine & Life Sciences
Radioisotopes Medicine & Life Sciences
Indium Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1972 2019

  • 3985 Citations
  • 140 Article
  • 1 Chapter
  • 1 Conference contribution
12 Citations (Scopus)

Efficacy and Safety of High-Specific-Activity 131 I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Pryma, D. A., Chin, B. B., Noto, R. B., Dillon, J. S., Perkins, S., Solnes, L., Kostakoglu, L., Serafini, A. N., Pampaloni, M. H., Jensen, J., Armor, T., Lin, T., White, T., Stambler, N., Apfel, S., DiPippo, V. A., Mahmood, S., Wong, V. & Jimenez, C., May 1 2019, In : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60, 5, p. 623-630 8 p.

Research output: Contribution to journalArticle

Open Access

Preoperative SPECT imaging as a tool for surgical planning in patients with axial neck and back pain

Brusko, G. D., Perez-Roman, R. J., Tapamo, H., Burks, S. S., Serafini, A. N. & Wang, M. Y., Dec 1 2019, In : Neurosurgical focus. 47, 6, p. E19

Research output: Contribution to journalArticle

Open Access
Neck Pain
Back Pain
Single-Photon Emission-Computed Tomography
Length of Stay
8 Citations (Scopus)

Phase II study of <sup>90</sup>Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

Lossos, I., Fabregas, J. C., Sengul, T., Miao, F., Goodman, D., Serafini, A. N., Hosein, P., Stefanovic, A., Rosenblatt, J. D. & Hoffman, J. E., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1750-1755 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Confidence Intervals
60 Citations (Scopus)

Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial

Ocean, A. J., Pennington, K. L., Guarino, M. J., Sheikh, A., Bekaii-Saab, T., Serafini, A. N., Lee, D., Sung, M. W., Gulec, S. A., Goldsmith, S. J., Manzone, T., Holt, M., O'Neil, B. H., Hall, N., Montero, A. J., Kauh, J., Gold, D. V., Horne, H., Wegener, W. A. & Goldenberg, D. M., Nov 15 2012, In : Cancer. 118, 22, p. 5497-5506 10 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Pancreatic Ductal Carcinoma
Maximum Tolerated Dose
22 Citations (Scopus)

Radiopharmaceuticals: When and how to use them to treat metastatic bone pain

Paes, F. M., Ernani, V., Hosein, P. & Serafini, A. N., Nov 1 2011, In : Journal of Supportive Oncology. 9, 6, p. 197-205 9 p.

Research output: Contribution to journalArticle

Bone and Bones
Neoplasm Metastasis